Neuroblastoma - Epidemiology Forecast to 2028

Neuroblastoma - Epidemiology Forecast to 2028

  • Pages: 60
  • Geography: Global
  • Delivery Timeline: 24 Hours
  • Publication: Jan, 2019
  • SKU: DIEI0149
  • Single User Price
    ()
    $3,250.00
  • Site User Price
    ()
    $6,500.00
  • Enterprise Price
    ()
    $9,750.00
Request Sample

Name*  
Email ID*  
Mobile*  
Company*  
Country*  
Zip Code*  
Address*  
Message*  
X

Request Sample Pages

Request Before Buy
Name*  
Email ID*  
Mobile*  
Company*  
Message*  
X

Inquire Before Buy

Send Friend
Name*  
Email ID*  
Mobile*  
Company*  
Message*  
X

Send to Friend

DelveInsight's "Neuroblastoma - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Neuroblastoma epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028. 

Markets Covered
• United States 
• EU5 (Germany, France, Italy, Spain, and the United Kingdom) 
• Japan
Study Period: 2016-2028
Neuroblastoma Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Neuroblastoma in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. 
The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Neuroblastoma outlook. It also includes the explanation of changing trends of epidemiology outlining the Neuroblastoma scenario. Neuroblastoma Epidemiology
Segmentation The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis.
The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Neuroblastoma thereby presenting the trends with detailed analysis, with the assumptions undertaken.
The data is presented in the form of graphs along with tables to effectively summarize the landscape. 

 

Report Scope
• The report covers detailed overview of Neuroblastoma explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns 
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan 
• The Neuroblastoma Report assesses the disease risk and burden and highlights the unmet needs 
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population Key strengths 
• 10 Year Forecast 
• 7MM Coverage 
• Total Cases in Neuroblastoma Key assessments 
• Patient Segmentation in Neuroblastoma 
• Neuroblastoma Risk & Burden 
• Factors driving growth in a specific Neuroblastoma patient population

 

1. KEY INSIGHTS 
2. DISEASE BACKGROUND AND OVERVIEW
3. INTRODUCTION 
3.1. STAGES OF NEUROBLASTOMA 
3.1.1. International Neuroblastoma Staging System (INSS) 
3.1.2. International Neuroblastoma Risk Group Staging System (INRGSS) 
3.2. NEUROBLASTOMA RISK GROUPS
3.2.1. Children’s Oncology Group (COG) Risk Group Classification 
3.2.2. International Neuroblastoma Risk Group (INRG) classification 
3.2.3. COG and INRG Classifications 
3.2.4. Current COG Neuroblastoma Risk Stratification 
3.3. SIGNS AND SYMPTOMS
3.4. ETIOLOGY 
3.5. PATHOGENESIS 
3.6. THERAPEUTIC TARGETS FOR NEUROBLASTOMA 
3.7. DIAGNOSIS 
4. EPIDEMIOLOGY AND PATIENT POPULATION 
5. KEY FINDINGS 
6. POPULATION AND FORECAST PARAMETERS 
7. 7MM TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA 
8. COUNTRY WISE-EPIDEMIOLOGY OF NEUROBLASTOMA 
8.1. United States 
8.1.1. Total Incident Patient Population of Neuroblastoma in the United States 
8.1.2. Distribution of Incident cases by Risk Groups – Neuroblastoma 
8.2. EU5 Countries 
8.3. Germany 
8.3.1. Total Incident Patient Population of Neuroblastoma in Germany 
8.3.2. Distribution of Incident cases by Risk Groups – Neuroblastoma 
8.4. France 
8.4.1. Total Incident Patient Population of Neuroblastoma in France 
8.4.2. Distribution of Incident cases by Risk Groups – Neuroblastoma 
8.5. United Kingdom 
8.5.1. Total Incident Patient Population of Neuroblastoma in the United Kingdom
8.5.2. Distribution of Incident cases by Risk Groups – Neuroblastoma 
8.6. Spain
8.6.1. Total Incident Patient Population of Neuroblastoma in Spain 
8.6.2. Distribution of Incident cases by Risk Groups – Neuroblastoma 
8.7. Italy 
8.7.1. Total Incident Patient Population of Neuroblastoma in Italy 
8.7.2. Distribution of Incident cases by Risk Groups – Neuroblastoma 
8.8. Japan 
8.8.1. Total Incident Patient Population of Neuroblastoma in Japan 
8.8.2. Distribution of Incident cases by Risk Groups – Neuroblastoma 
9. APPENDIX 
10. REPORT METHODOLOGY 
10.1. Sources used
11. DELVEINSIGHT CAPABILITIES 
12. DISCLAIMER 
13. ABOUT DELVEINSIGHT

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Table 1: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM 
Table 2: Total Prevalent/Incident Cases of the Neuroblastoma in 7MM by Countries 
Table 3: Prevalent/Incident Cases of the Neuroblastoma in United States (2016-2028) 
Table 4: Sub-Type Specific cases of the Neuroblastoma in United States (2016-2028)
Table 5: Sex- Specific Cases of the Neuroblastoma in United States (2016-2028)
Table 6: Diagnosed Cases of the Neuroblastoma in United States (2016-2028) 
Table 7: Prevalent/Incident Cases of the Neuroblastoma in Germany (2016-2028) 
Table 8: Sub-Type Specific cases of the Neuroblastoma in Germany (2016-2028) 
Table 9: Sex- Specific Cases of the Neuroblastoma in Germany (2016-2028) 
Table 10: Diagnosed Cases of the Neuroblastoma in Germany (2016-2028) 
Table 11: Prevalent/Incident Cases of the Neuroblastoma in France (2016-2028) 
Table 12: Sub-Type Specific cases of the Neuroblastoma in France (2016-2028) 
Table 13: Sex- Specific Cases of the Neuroblastoma in France (2016-2028) 
Table 14: Diagnosed Cases of the Neuroblastoma in France (2016-2028) 
Table 15: Prevalent/Incident Cases of the Neuroblastoma in Italy (2016-2028) 
Table 16: Sub-Type Specific cases of the Neuroblastoma in Italy (2016-2028) 
Table 17: Sex- Specific Cases of the Neuroblastoma in Italy (2016-2028) 
Table 18: Diagnosed Cases of the Neuroblastoma in Italy (2016-2028) 
Table 19: Prevalent/Incident Cases of the Neuroblastoma in Spain (2016-2028) 
Table 20: Sub-Type Specific cases of the Neuroblastoma in Spain (2016-2028) 
Table 21: Sex- Specific Cases of the Neuroblastoma in Spain (2016-2028) 
Table 22: Diagnosed Cases of the Neuroblastoma in Spain (2016-2028) 
Table 23: Prevalent/Incident Cases of the Neuroblastoma in UK (2016-2028) 
Table 24: Sub-Type Specific cases of the Neuroblastoma in UK (2016-2028) 
Table 25: Sex- Specific Cases of the Neuroblastoma in UK (2016-2028)
Table 26: Diagnosed Cases of the Neuroblastoma in UK (2016-2028) 
Table 27: Prevalent/Incident Cases of the Neuroblastoma in Japan (2016-2028) 
Table 28: Sub-Type Specific cases of the Neuroblastoma in Japan (2016-2028) 
Table 29: Sex- Specific Cases of the Neuroblastoma in Japan (2016-2028) 
Table 30: Diagnosed Cases of the Neuroblastoma in Japan (2016-2028)

FIGURE 1: STAGING OF NEUROBLASTOMA
FIGURE 2: SIGNS AND SYMPTOMS OF NEUROBLASTOMA
FIGURE 3: PATHOGENESIS OF NEUROBLASTOMA
FIGURE 4: THERAPEUTIC TARGETS FOR NEUROBLASTOMA
FIGURE 5: INITIAL DIAGNOSTIC WORK FOR NEUROBLASTOMA
FIGURE 6: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE 7MM (2016-2028)
FIGURE 7: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED STATES (2016-2028)
FIGURE 8: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED STATES (2016-2028)
FIGURE 9: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN GERMANY (2016-2028)
FIGURE 10: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN GERMANY (2016-2028)
FIGURE 11: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN FRANCE (2016-2028)
FIGURE 12: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN FRANCE (2016-2028)
FIGURE 13: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN THE UNITED KINGDOM (2016-2028)
FIGURE 14: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN THE UNITED KINGDOM (2016-2028)
FIGURE 15: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN SPAIN (2016-2028)
FIGURE 16: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN SPAIN (2016-2028)
FIGURE 17: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN ITALY (2016-2028)
FIGURE 18: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN ITALY (2016-2028)
FIGURE 19: TOTAL INCIDENT PATIENT POPULATION OF NEUROBLASTOMA IN JAPAN (2016-2028)
FIGURE 20: INCIDENT PATIENT POPULATION OF NEUROBLASTOMA BY RISK GROUPS IN JAPAN (2016-2028)

 

Key Companies
Speak to Analyst
Name*  
Email ID*  
Mobile*  
Company*  
Country*  
Zip Code*  
Specific Filed of Interest*  
X

Speak to Analyst

+1(919)321-6187

Related Reports

Contact Us

Phone

India: +91-11-45689769, +91-9650213330

Email

info@delveinsight.com

Address

New Delhi-110075, India

Address

304 S. Jones Blvd #2432, Las Vegas NV 89107

Phone

Outside India: +1(919)321-6187

Latest Tweets

Copyright © 2018 Delveinsight.